Lupin

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

ServiceNow (NYSE: NOW) raises AI contract target to $1.7bn, but shares plunge 17% after hours

HanAll F&B files rice noodle patent after 6 tonnes of testing as Korea seeks new uses for domestic rice

HanAll F&B plans rice pasta and naengmyeon expansion after filing patent for improved noodle manufacturing

Infographic showing EPACK Prefab Technologies Limited’s ₹100 crore Ghiloth manufacturing facility in Rajasthan, highlighting commercial production, expanded pre-engineered building and insulated-panel capacity, and existing panel utilisation of 49.5%.

EPACK Prefab Technologies expands Rajasthan manufacturing capacity with Rs 1,376cr order book, but margins remain under pressure

Infographic showing Molecular Partners’ plan to cut up to 55 jobs, or about 44% of its workforce, while refocusing on targeted radiotherapy and lead Radio-DARPin candidate MP0712 ahead of expected efficacy data in 2027.

Molecular Partners (NASDAQ: MOLN) plans 44% workforce cut as MP0712 becomes central to strategy

Lupin collaborates with AbbVie for $977m MALT1 inhibitor program targeting hematological cancers

Indian pharmaceutical company Lupin has entered a landmark agreement to out-license its MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation…

bypharmanewsdaily

December 25, 2018

Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics

Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by…

bySrinath

October 15, 2017

The Latest

ServiceNow (NYSE: NOW) raises AI contract target to $1.7bn, but shares plunge 17% after hours

HanAll F&B plans rice pasta and naengmyeon expansion after filing patent for improved noodle manufacturing

EPACK Prefab Technologies expands Rajasthan manufacturing capacity with Rs 1,376cr order book, but margins remain under pressure

Molecular Partners (NASDAQ: MOLN) plans 44% workforce cut as MP0712 becomes central to strategy

Lupin collaborates with AbbVie for $977m MALT1 inhibitor program targeting hematological cancers

Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics

ServiceNow (NYSE: NOW) raises AI contract target to $1.7bn, but shares plunge 17% after hours

HanAll F&B plans rice pasta and naengmyeon expansion after filing patent for improved noodle manufacturing

EPACK Prefab Technologies expands Rajasthan manufacturing capacity with Rs 1,376cr order book, but margins remain under pressure

Molecular Partners (NASDAQ: MOLN) plans 44% workforce cut as MP0712 becomes central to strategy

Australia budget update faces fresh pressure as inflation hits 4.3%

Evolution Mining’s Carnaby acquisition nears completion as A$22m Glencore share settlement advances

UK immigration overhaul: Shabana Mahmood prepares 10-year settlement rule

Neuren Pharmaceuticals (ASX: NEU) gains fourth US orphan drug designation for NNZ-2591